Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Lt.../ US8816242098 /
TEVA
04.09.2024 22:10:00
|
Изменение
+0.44
|
Объем сделки |
Бид2:00:00 |
Предложение2:00:00 |
Рыночная капитализация |
Дивидендная доходность |
Коэффициент Цена/Доход |
18.96USD
|
+2.38%
|
12.48 млн Оборот: 150.56 млн |
18.77Величина цены спроса: 200 |
19.03Величина цены предложения: 100 |
-USD |
- |
- |
Описание деятельности
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies.
Правление & Наблюдательный совет
Исполнительный директор |
Kåre Schultz |
Правление |
Eli Kalif, David M. Stark, Dr. Hafrun Fridriksdottir, Eli Shani, Eric Drapé, Galia Inbar, Lori Queisser, Mark Sabag, Nir Baron, Richard Daniell, Sven Dethlefs |
Наблюдательный совет |
Dr. Sol J. Barer, Amir Elstein, Dr. Perry D. Nisen, Dr. Tal Zaks, Gerald M. Lieberman, Janet S. Vergis, Jean-Michel Halfon, Kåre Schultz, Nechemia J. Peres, Prof. Ronit Satchi-Fainaro, Roberto A. Mignone, Rosemary A. Crane |
Данные компании
Имя: |
Teva Pharmaceuticals Industries Ltd. |
Адрес: |
5 Basel St.,Petach Tikva 49131, Israel |
Телефон: |
+972-3-914-8171 |
Факс: |
+972-3-914-8678 |
E-mail: |
-
|
Интернет: |
www.tevapharm.com |
Индустрия: |
Healthcare |
Сектор: |
Pharmaceutical Industry |
Подсектор: |
Pharmaceuticals |
Конец финансового года: |
31.12 |
Акции в свободном обращении: |
88.20% |
Дата IPO: |
- |
Основные акционеры
Freefloat |
|
88.20% |
Capital Research and Management Company |
|
11.80% |